Francisco Gascón-Giménez

1PUBLICATIONS
10CO-AUTHORS
Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Pageof 1

Frequent Collaborators

1 joint publications

Lucienne Costa-Frossard

1 joint publications

Daniel Apolinar García-Estévez

1 joint publications

María Rosario Blasco-Quílez

1 joint publications

José E Meca-Lallana